| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
624 |
183 |
$26K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
612 |
178 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
47 |
37 |
$2K |
| 87481 |
|
47 |
37 |
$617.56 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
30 |
21 |
$158.13 |
| 87641 |
|
31 |
22 |
$150.07 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
30 |
21 |
$128.35 |
| 87500 |
|
30 |
21 |
$123.52 |
| 87640 |
|
47 |
37 |
$123.52 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
47 |
37 |
$123.52 |
| 87653 |
|
47 |
37 |
$120.84 |
| 87496 |
|
17 |
16 |
$0.00 |
| 87532 |
|
17 |
16 |
$0.00 |
| 87486 |
|
17 |
16 |
$0.00 |
| 87503 |
|
17 |
16 |
$0.00 |
| 87541 |
|
17 |
16 |
$0.00 |
| 87581 |
|
17 |
16 |
$0.00 |
| 87556 |
|
17 |
16 |
$0.00 |
| 87498 |
|
17 |
16 |
$0.00 |
| 87631 |
|
17 |
16 |
$0.00 |
| 86413 |
|
17 |
16 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
16 |
$0.00 |
| 87634 |
|
17 |
16 |
$0.00 |